Home »
Academic Articles »
Xanthine Oxidase-Induced Inflammatory Responses in Respiratory Epithelial Cells: A Review in Immunopathology of COVID-19
Xanthine Oxidase-Induced Inflammatory Responses in Respiratory Epithelial Cells: A Review in Immunopathology of COVID-19
Irandi Putra Pratomo
(Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia)
Dimas R. Noor
(Human Cancer Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia)
Kusmardi Kusmardi
(Human Cancer Research Center, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia)
Andriansjah Rukmana
(Department of Microbiology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia)
Rafika I. Paramita
(Bioinformatics Core Facilities, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia)
Linda Erlina
(Bioinformatics Core Facilities, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia)
Fadilah Fadilah
(Bioinformatics Core Facilities, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia)
Anggi Gayatri
(Department of Pharmacology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia)
Magna Fitriani
(Universitas Indonesia University Hospital, Universitas Indonesia, Depok, Indonesia)
Tommy T. H. Purnomo
(Universitas Indonesia University Hospital, Universitas Indonesia, Depok, Indonesia)
Anna Ariane
(Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia–Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia)
Rudi Heryanto
(Department of Chemistry, Faculty of Mathematics and Natural Sciences, IPB University, Bogor, Indonesia)
Aryo Tedjo
(Drug Development Research Cluster, Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia)
Journal: International Journal of Inflammation
•
• Wiley
• ISSN: 2090-8040
Abstract
Xanthine oxidase (XO) is an enzyme that catalyzes the production of uric acid and superoxide radicals from purine bases: hypoxanthine and xanthine and is also expressed in respiratory epithelial cells. Uric acid, which is also considered a danger associated molecule pattern (DAMP), could trigger a series of inflammatory responses by activating the inflammasome complex path and NF-κB within the endothelial cells and by inducing proinflammatory cytokine release. Concurrently, XO also converts the superoxide radicals into hydroxyl radicals that further induce inflammatory responses. These conditions will ultimately sum up a hyperinflammation condition commonly dubbed as cytokine storm syndrome (CSS). The expression of proinflammatory cytokines and neutrophil chemokines may be reduced by XO inhibitor, as observed in human respiratory syncytial virus (HRSV)-infected A549 cells. Our review emphasizes that XO may have an essential role as an anti-inflammation therapy for respiratory viral infection, including coronavirus disease 2019 (COVID-19).
Irandi Putra Pratomo, Dimas R. Noor, Kusmardi Kusmardi, et al. (2021). "Xanthine Oxidase-Induced Inflammatory Responses in Respiratory Epithelial Cells: A Review in Immunopathology of COVID-19". International Journal of Inflammation. https://doi.org/10.1155/2021/1653392